- Home
- BMY vs UBS Comparison
BMY vs UBS Comparison
Compare BMY & UBS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | BMY | UBS |
|---|---|---|
| Founded | 1887 | 1862 |
| Country | United States | Switzerland |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Major Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 110.2B | 120.6B |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | BMY | UBS |
|---|---|---|
| Price | $54.88 | $47.47 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 14 | 2 |
| Target Price | $57.64 | ★ $60.30 |
| AVG Volume (30 Days) | ★ 12.2M | 1.8M |
| Earning Date | 02-05-2026 | 02-04-2026 |
| Dividend Yield | ★ 4.59% | 1.55% |
| EPS Growth | N/A | ★ 84.33 |
| EPS | ★ 2.97 | 2.21 |
| Revenue | $48,034,000,000.00 | ★ $48,193,000,000.00 |
| Revenue This Year | $0.28 | $5.16 |
| Revenue Next Year | N/A | $3.74 |
| P/E Ratio | ★ $18.50 | $20.72 |
| Revenue Growth | 1.26 | ★ 2.09 |
| 52 Week Low | $42.52 | $25.75 |
| 52 Week High | $63.33 | $48.43 |
Technical Indicators
Market Signals| Indicator | BMY | UBS |
|---|---|---|
| Relative Strength Index (RSI) | 54.65 | 61.45 |
| Support Level | $53.55 | $46.37 |
| Resistance Level | $55.53 | $48.26 |
| Average True Range (ATR) | 1.18 | 0.56 |
| MACD | -0.31 | -0.26 |
| Stochastic Oscillator | 58.48 | 53.88 |
Price Performance
Historical ComparisonAbout BMY Bristol-Myers Squibb Company
Bristol-Myers Squibb discovers, develops, and markets drugs for various therapeutic areas, such as cardiovascular, cancer, and immune disorders. A key focus for Bristol is immuno-oncology, where the firm is a leader in drug development. Bristol derives close to 70% of total sales from the US, showing a higher dependence on the US market than most of its peer group.
About UBS UBS Group AG Registered
UBS is a global financial institution built around its core strength in wealth management, serving high and ultra-high-net-worth individuals. In Switzerland, it also operates as a traditional retail and commercial bank. Its investment bank and asset management divisions complement the wealth business, providing tailored solutions to UBS clients while serving third-party customers by leveraging UBS' global reach and expertise.